Inhibition of p53 degradation leads to upregulation of the epithelial marker E-cadherin and downregulation of Snail and Slug as mesenchymal markers; this leads to suppression of EMT and sensitization of cancer cells to CP therapy [312]. This evidence concerns the gene CDH1 and cancer.